Last Update 21 Mar 26

Fair value Decreased 59%

SNBR: Marketing Reset And New Mattress Portfolio Will Support Future Upside

Sleep Number's updated fair value estimate has shifted from $11.00 to $4.50. This reflects analysts' recent cuts to price targets to around $4 to $5 as they weigh ongoing Neutral ratings against limited sales traction, despite some progress in marketing and new product launches.

Analyst Commentary

Recent Street research has centered on lower price targets in the US$4 to US$5 range and a consistent Neutral stance. This reflects mixed views on how quickly Sleep Number can translate its current initiatives into stronger fundamentals.

Bullish Takeaways

Some bullish analysts point to recent Q4 revenue and EBITDA results as evidence that execution can support the current valuation, even if the shares are already pricing in many concerns.
Marketing spend and new product launches are seen as building blocks for future growth. If successful, these efforts could help justify upside from targets in the mid single digits over time.
Maintaining Neutral rather than negative ratings signals that analysts still see a path for the company to improve its growth profile and narrow the gap between current trading levels and prior, higher price targets.
The shift from previous, higher target ranges to US$4 to US$5 is viewed by some as resetting expectations to a level where incremental execution wins could have a clearer impact on valuation.

Bearish Takeaways

Bearish analysts focus on the cut in price targets from prior levels of US$10 to US$12 down to US$4 to US$5, which they see as reflecting ongoing uncertainty around the company’s ability to deliver consistent growth.
The commentary that Q4 outperformance on revenue and EBITDA has not yet led to a visible improvement in sales trends raises concerns about the durability and quality of recent results.
There is caution around whether higher marketing spend and product launches can translate into enough volume and margin support to re rate the stock meaningfully from its current fair value estimate.
Neutral ratings combined with lower targets suggest some analysts are reluctant to assign higher multiples until there is clearer evidence that recent initiatives are driving sustainable sales traction.

What's in the News

Sleep Number filed its 10-K on March 12, 2026, for the period ending January 3, 2026. Auditor Deloitte & Touche LLP issued an unqualified opinion that still expressed doubt about the company’s ability to continue as a going concern (10-K filing).
The company announced its largest product reset in almost a decade, rolling out a simplified mattress portfolio of seven beds across three Collections. The reset is aimed at offering a luxury experience at more approachable price points starting March 23, 2026 (company announcement).
The ComfortMode Collection, starting at US$1,599 for a Queen, focuses on comfort and temperature balancing without requiring an app or connectivity. The ComfortMode Lux version will start at US$2,099 for a Queen and will be available March 23, 2026 (company announcement).
The ComfortNext Collection, starting at US$2,999 for a Queen, introduces Sleep Number’s first Tri-Brid design that combines micro coils, foam and air. It includes app controlled smart features across three new mattresses priced up to US$4,499 for a Queen (company announcement).
The Climate Collection, starting at US$5,499 for a Queen and including the Climate360 model at US$9,999, continues to feature active heating and cooling with smart technology. It is supported by SleepIQ data indicating up to 52.5 minutes more restful sleep per night for Climate360 sleepers using the SmartTemp program compared with turning it off (company announcement).

Valuation Changes

Fair Value: The updated fair value estimate has fallen significantly from $11.00 to $4.50 per share, bringing it closer to recent analyst price targets in the $4 to $5 range.
Discount Rate: The discount rate assumption is unchanged at 12.33%, indicating that the required return used in the valuation framework remains the same.
Revenue Growth: The revenue growth input has risen from about 69.7% to a very large value, indicating a much higher growth assumption now embedded in the model.
Net Profit Margin: The profit margin assumption has shifted from about 19.1% to a very large value, implying a much higher projected earnings contribution relative to revenue.
Future P/E: The future P/E multiple has fallen significantly from 127.3x to 5.2x, indicating a much lower valuation multiple applied to projected earnings in the revised model.

3 views

Key Takeaways

High debt and limited capital flexibility, combined with lack of near-term growth drivers, threaten margins and risk future earnings as macro pressures persist.
Efforts to broaden distribution and simplify offerings could weaken brand differentiation and innovation, making Sleep Number vulnerable to intensified competition and commoditization.
Enhanced marketing efficiency, cost discipline, product simplification, omni-channel expansion, and proprietary tech position Sleep Number for resilient growth, margin improvement, and broader market relevance.

Catalysts

About Sleep Number

Designs, manufactures, markets, distributes, retails, and services sleep solutions in the United States.What are the underlying business or industry changes driving this perspective?

Management signals a long path to top-line recovery despite ongoing cost cuts; with flat second-half revenues expected and no material growth initiatives realized until 2026, investor optimism around near-term revenue growth and operating leverage appears unfounded, putting forward multiples at risk. (Impacts: Future sales, operating margins)
The company's strategy to broaden distribution-including digital-first, retail partnerships, and emerging platforms-may dilute brand differentiation and margin structure, especially as competition in smart bed and connected home categories intensifies and price pressure from commoditized DTC models increases. (Impacts: Gross margins, average selling price, long-term revenue growth)
High debt burden and dependence on favorable lender negotiations continue to constrain capital allocation flexibility, making long-term investments in innovation or large-scale channel expansion riskier and increasing the likelihood of future margin and earnings compression if macro conditions or lender terms tighten. (Impacts: Interest expenses, net margins, long-term earnings)
CEO and CFO emphasized needing to make the product assortment, pricing, and retail experience simpler and more accessible to reach a broader customer base, implicitly acknowledging that demographic shifts-such as the aging U.S. population, slower homeownership growth, and greater renting-are already pressuring Sleep Number's premium positioning and suppressing addressable market growth. (Impacts: Sales volume, average selling price, revenue growth)
Rapid operational restructuring, including deep G&A and R&D cuts, risks eroding Sleep Number's innovation pipeline and long-term competitive moat, especially as larger industry trends drive increased integration of IoT, AI, and health-tracking into sleep products-potentially leading to brand commoditization and weaker gross margins if competitors outpace Sleep Number in R&D. (Impacts: Long-term gross margins, competitive positioning, innovation-driven revenue)

Sleep Number Earnings and Revenue Growth

Sleep Number Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Sleep Number's revenue will grow by 3.0% annually over the next 3 years.
Analysts assume that profit margins will increase from -9.3% today to 1.8% in 3 years time.
Analysts expect earnings to reach $28.4 million (and earnings per share of $1.1) by about March 2029, up from -$132.0 million today.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 5.3x on those 2029 earnings, up from -0.5x today. This future PE is lower than the current PE for the US Specialty Retail industry at 19.1x.
Analysts expect the number of shares outstanding to grow by 0.9% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 12.33%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Significant improvements in marketing efficiency-including a 24% increase in conversion year-over-year and ongoing optimization of programs, channels, and customer targeting-could drive higher future revenue without proportionally increasing spend, boosting both top-line and margins over time.
Aggressive cost reduction efforts ($130 million targeted in 2025) through streamlining G&A, R&D, and organizational layers, as well as supply chain and manufacturing efficiencies, have already led to improved EBITDA margins; further discipline in cost management may continue to expand net margins and earnings, even in a soft sales environment.
Plans to enhance and simplify the product lineup, backed by proprietary sleep data and ongoing customer research, position the brand to broaden its addressable market and improve relevance and conversion, supporting future revenue growth as consumer demand for personalized wellness products rises.
Commitment to omni-channel expansion-including new digital-first partnerships and a holistic ecosystem approach-has the potential to drive market share gains and reduce dependence on any single retail channel, supporting resilient revenue growth and potentially lowering distribution costs long-term.
Strength in proprietary technology (SleepIQ®), historical gross margin improvements despite unit deleverage, and an explicit focus on innovation and product differentiation, position Sleep Number to benefit from ongoing secular trends in health, wellness, and connected home adoption, which could underpin long-term revenue and margin expansion.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $4.5 for Sleep Number based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $5.0, and the most bearish reporting a price target of just $4.0.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $1.5 billion, earnings will come to $28.4 million, and it would be trading on a PE ratio of 5.3x, assuming you use a discount rate of 12.3%.
Given the current share price of $2.83, the analyst price target of $4.5 is 37.1% higher.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Sleep Number?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Despite Margin Risks, Digital Shifts Will Drive Future Turnaround